Intradermal and subcutaneous leiomyosarcoma: A clinicopathological and immunohistochemical study of 41 cases

被引:82
作者
Jensen, ML
Jensen, OM
Michalski, W
Nielsen, OS
Keller, J
机构
[1] AARHUS UNIV HOSP, CTR BONE & SOFT TISSUE TUMOURS, DEPT ORTHOPAED SURG, DK-8000 AARHUS, DENMARK
[2] AARHUS UNIV HOSP, CTR BONE & SOFT TISSUE TUMOURS, DEPT CLIN & EXPT ONCOL, DK-8000 AARHUS, DENMARK
[3] AARHUS UNIV HOSP, CTR BONE & SOFT TISSUE TUMOURS, DEPT PATHOL, DK-8000 AARHUS, DENMARK
关键词
D O I
10.1111/j.1600-0560.1996.tb01435.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Superficial leiomyosarcomas are rare tumours. The lesions confined to the dermis, contrary to those involving the subcutis, have been reported to carry a favourable prognosis. A retrospective study of 41 consecutive cases of surgically treated intradermal and subcutaneous leiomyosarcomas was undertaken in order to determine the prognostic factors that may influence the survival of these patients. Seven rumours were predominantly intradermal and 34 involved the subcutaneous tissue. Fifty-four percent of the tumours were located in the lower extremities. All cases stained positively for smooth muscle antigen and 66% for desmin. The tumours were classified with regard to tumour grade I (low grade, 3%), II (intermediate, 12%), IIIA (high grade, 46%) and IIIB (high grade, 39%). In all patients, follow-up information was available. Mean follow-up time was 5 years. The patients with intradermal tumours were all alive without signs of recurrence, whereas 14 of those with leiomyosarcomas involving the subcutis have died with pulmonary metastases. Our study confirms that ''pure'' intradermal leiomyosarcomas independent of tumour grade behave in a benign fashion, probably due to small tumour size. Tumour size greater than or equal to 5 cm, deep localization with fascia involvement, and high malignancy grade (IIIB) were found to deteriorate survival based on a univariate analysis. However, in a multivariate analysis only tumour size was found to be an independent prognostic factor. (C) Munksgaard 1996.
引用
收藏
页码:458 / 463
页数:6
相关论文
共 22 条
[1]  
BENTZEN SM, 1988, CANCER-AM CANCER SOC, V62, P194, DOI 10.1002/1097-0142(19880701)62:1<194::AID-CNCR2820620129>3.0.CO
[2]  
2-8
[3]  
BOENISCH T, 1989, IMMUNOHISTOCHEMICAL, V13
[4]   KP-1 - NOT A SPECIFIC MARKER - STAINING OF 137 SARCOMAS, 48 LYMPHOMAS, 28 CARCINOMAS, 7 MALIGNANT MELANOMAS AND 8 CYSTOSARCOMA-PHYLLODES [J].
CASSIDY, M ;
LOFTUS, B ;
WHELAN, A ;
SABT, B ;
HICKEY, D ;
HENRY, K ;
LEADER, M .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1994, 424 (06) :635-640
[5]  
COX DR, 1972, J R STAT SOC B, V34, P187
[6]  
DAHL I, 1974, PATHOL EUR, V9, P307
[7]  
ENZINGER FM, 1995, SOFT TISSUE TUMOURS, P503
[8]  
FIELDS JP, 1981, CANCER, V47, P156, DOI 10.1002/1097-0142(19810101)47:1<156::AID-CNCR2820470127>3.0.CO
[9]  
2-#
[10]  
GOLDBLUM JR, 1995, ARCH PATHOL LAB MED, V119, P238